KURE. AI, INC.
SHAKER HEIGHTS, OH
What changed
NIH R37 · $0.5M · Mitochondrial bioenergetics and colorectal cancer
7w agoGrant renewalMay 25, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 55 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R44 · $1.1M · non-dilutive
Sep 15, 2025KURE. AI, INC. · PI WALD, DAVID · NCI · award ends Aug 31, 2027 · Ultra-fast manufactured CAR-T therapy
NIH RePORTER · NIH RePORTER 11184038 (opens the source filing in a new tab)
- Grant
R01 · $476k · non-dilutive
Mar 15, 2025CASE WESTERN RESERVE UNIVERSITY · PI TIROSH, BOAZ · NCI · award ends Feb 28, 2030 · Creating a transient metabolic catastrophe for AML therapy
NIH RePORTER · NIH RePORTER 11300980 (opens the source filing in a new tab)
- Grant
R37 · $535k · non-dilutive
Feb 19, 2024WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FISHER-WELLMAN, KELSEY H · NCI · award ends May 31, 2029 · Mitochondrial bioenergetics and colorectal cancer
NIH RePORTER · NIH RePORTER 11328791 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources